Immunocore Holdings plc
IMCR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001671927
No open-market purchases or sales by Immunocore Holdings plc insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $1.65B in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Immunocore Holdings plc changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 130 | 1 | 116 | −13 |
| Shares | 45.3M | 1.50K | 45.4M | +116.1K (+0.3%) |
| Value | $1.41B | $46.7K | $1.34B | −$69.8M (−5.0%) |
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (14)
Institutions that held Immunocore Holdings plc at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Kynam Capital Management, LP | 1,225,576 | $36.2M | 2.38% |
| Deep Track Capital, LP | 519,376 | $15.3M | 0.57% |
| Point72 Asset Management, L.P. | 403,304 | $11.9M | 0.03% |
| BNP Paribas Arbitrage, SA | 193,115 | $5.70M | 0.00% |
| Jefferies Financial Group Inc. | 165,000 | $4.87M | 0.05% |
| Cubist Systematic Strategies, LLC | 106,600 | $3.14M | 0.05% |
| Crestline Management, LP | 24,960 | $736.3K | 0.03% |
| Groupama Asset Managment | – | $510.3K | 0.01% |
| Tema ETFs LLC | 11,194 | $330.2K | 0.14% |
| GF Fund Management Co. Ltd. | 831 | $24.5K | 0.00% |
| R Squared Ltd | 350 | $10.3K | 0.01% |
| SBI Securities Co., Ltd. | 109 | $3.22K | 0.00% |
| Jones Financial Companies LLLP | 78 | $2.30K | 0.00% |
| Northwestern Mutual Wealth Management Co | 7 | $207 | 0.00% |
Sold out (27)
Institutions that held Immunocore Holdings plc at the end of Q3 2024 and filed for Q4 2024 without it.
Not filed for Q4 2024 yet (1)
Institutions that held Immunocore Holdings plc at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| PEAK6 Investments LLC | 1,500 | $46.7K |